These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11827039)

  • 1. Selective production of staplabin and SMTPs in cultures of Stachybotrys microspora fed with precursor amines.
    Hu W; Narasaki R; Ohyama S; Hasumi K
    J Antibiot (Tokyo); 2001 Nov; 54(11):962-6. PubMed ID: 11827039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of fibrinolysis by SMTP-7 and -8, novel staplabin analogs with a pseudosymmetric structure.
    Hu W; Ohyama S; Hasumi K
    J Antibiot (Tokyo); 2000 Mar; 53(3):241-7. PubMed ID: 10819294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staplabin, a novel fungal triprenyl phenol which stimulates the binding of plasminogen to fibrin and U937 cells.
    Shinohara C; Hasumi K; Hatsumi W; Endo A
    J Antibiot (Tokyo); 1996 Oct; 49(10):961-6. PubMed ID: 8968387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMTP-4D, -5D, -6D, -7D and -8D, a new series of the non-lysine-analog plasminogen modulators with a D-amino acid moiety.
    Hu W; Kitano Y; Hasumi K
    J Antibiot (Tokyo); 2003 Oct; 56(10):832-7. PubMed ID: 14700276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of SMTP-3, 4, 5 and -6, novel analogs of staplabin, and their effects on plasminogen activation and fibrinolysis.
    Hasumi K; Ohyama S; Kohyama T; Ohsaki Y; Takayasu R; Endo A
    J Antibiot (Tokyo); 1998 Dec; 51(12):1059-68. PubMed ID: 10048563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMTP-1 and -2, novel analogs of staplabin produced by Stachybotrys microspora IFO30018.
    Kohyama T; Hasumi K; Hamanaka A; Endo A
    J Antibiot (Tokyo); 1997 Feb; 50(2):172-4. PubMed ID: 9099229
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure-activity relationships of 11 new congeners of the SMTP plasminogen modulator.
    Hasegawa K; Koide H; Hu W; Nishimura N; Narasaki R; Kitano Y; Hasumi K
    J Antibiot (Tokyo); 2010 Oct; 63(10):589-93. PubMed ID: 20842143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-SMTP, a key precursor for the biosynthesis of the SMTP plasminogen modulators.
    Nishimura Y; Suzuki E; Hasegawa K; Nishimura N; Kitano Y; Hasumi K
    J Antibiot (Tokyo); 2012 Sep; 65(9):483-5. PubMed ID: 22714026
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation and absolute configuration of SMTP-0, a simplest congener of the SMTP family nonlysine-analog plasminogen modulators.
    Hasumi K; Hasegawa K; Kitano Y
    J Antibiot (Tokyo); 2007 Jul; 60(7):463-8. PubMed ID: 17721006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel embolic model of cerebral infarction and evaluation of Stachybotrys microspora triprenyl phenol-7 (SMTP-7), a novel fungal triprenyl phenol metabolite.
    Hashimoto T; Shibata K; Nobe K; Hasumi K; Honda K
    J Pharmacol Sci; 2010; 114(1):41-9. PubMed ID: 20703011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of SMTP Targeting Plasminogen and Soluble Epoxide Hydrolase on Thrombolysis, Inflammation, and Ischemic Stroke.
    Hasumi K; Suzuki E
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477998
    [No Abstract]   [Full Text] [Related]  

  • 12. A new series of the SMTP plasminogen modulators with a phenylamine-based side chain.
    Koide H; Hasegawa K; Nishimura N; Narasaki R; Hasumi K
    J Antibiot (Tokyo); 2012 Jul; 65(7):361-7. PubMed ID: 22511228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMTP (Stachybotrys microspora triprenyl phenol) enhances clot clearance in a pulmonary embolism model in rats.
    Hu W; Narasaki R; Nishimura N; Hasumi K
    Thromb J; 2012 Jan; 10(1):2. PubMed ID: 22230042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stachybotrys microspora triprenyl phenol-7, a novel fibrinolytic agent, suppresses superoxide production, matrix metalloproteinase-9 expression, and thereby attenuates ischemia/reperfusion injury in rat brain.
    Akamatsu Y; Saito A; Fujimura M; Shimizu H; Mekawy M; Hasumi K; Tominaga T
    Neurosci Lett; 2011 Oct; 503(2):110-4. PubMed ID: 21871536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of fibrin binding and activation of plasminogen by staplabin through induction of a conformational change in plasminogen.
    Takayasu R; Hasumi K; Shinohara C; Endo A
    FEBS Lett; 1997 Nov; 418(1-2):58-62. PubMed ID: 9414095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoprene Side-chain of SMTP is Essential for Soluble Epoxide Hydrolase Inhibition and Cellular Localization.
    Otake S; Ogawa N; Kitano Y; Hasumi K; Suzuki E
    Nat Prod Commun; 2016 Feb; 11(2):223-7. PubMed ID: 27032207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of the plasminogen modulator SMTP with respect to the inhibition of soluble epoxide hydrolase.
    Matsumoto N; Suzuki E; Tsujihara K; Nishimura Y; Hasumi K
    J Antibiot (Tokyo); 2015 Nov; 68(11):685-90. PubMed ID: 25966853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent efficacy of Stachybotrys microspora triprenyl phenol-7, a small molecule having anti-inflammatory and antioxidant activities, in a mouse model of acute kidney injury.
    Shibata K; Hashimoto T; Hasumi K; Nobe K
    Eur J Pharmacol; 2021 Nov; 910():174496. PubMed ID: 34506776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new series of the SMTP plasminogen modulator with a phenylglycine-based side chain.
    Koide H; Narasaki R; Hasegawa K; Nishimura N; Hasumi K
    J Antibiot (Tokyo); 2012 Feb; 65(2):91-3. PubMed ID: 22108677
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the effects of a new series of SMTPs in the acetic acid-induced embolic cerebral infarct mouse model.
    Shibata K; Hashimoto T; Hasumi K; Honda K; Nobe K
    Eur J Pharmacol; 2018 Jan; 818():221-227. PubMed ID: 29107671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.